Safety and efficacy of salvage surgery for non-small cell lung cancer: a retrospective study of 46 patients from four Keio-affiliated hospitals-Reference-Cited by-同舟云学术

Safety and efficacy of salvage surgery for non-small cell lung cancer: a retrospective study of 46 patients from four Keio-affiliated hospitals

Published:2022-03-28 Issue:10 Volume:70 Page:891-899
ISSN:1863-6705
Container-title:General Thoracic and Cardiovascular Surgery
language:en
Short-container-title:Gen Thorac Cardiovasc Surg

Author:

Suzuki Shigeki,Asakura Keisuke^ORCID,Okui Masayuki,Sawafuji Makoto,Shigenobu Takao,Tajima Atsushi,Kaseda Kaoru,Masai Kyohei,Hishida Tomoyuki,Asamura Hisao

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,General Medicine,Surgery

Link

https://link.springer.com/content/pdf/10.1007/s11748-022-01808-4.pdf

Reference27 articles.

1. Shepherd FA, Ginsberg R, Patterson GA, Feld R, Goss PE, Pearson FG, et al. Is there ever a role for salvage operations in limited small-cell lung cancer? J Thorac Cardiovasc Surg. 1991;101:196–200.

2. Koizumi T, Aoki T, Saito M, Yamato Y, Furuyashiki G, Kitahara A, et al. Salvage surgery to treat tumor regrowth after stereotactic body radiotherapy in primary non-small cell lung cancer. J Thorac Dis. 2020;12:5289–98.

3. Senthi S, Lagerwaard FJ, Haasbeek CJ, Slotman BJ, Senan S. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis. Lancet Oncol. 2012;13:802–9.

4. Lagerwaard FJ, Verstegen NE, Haasbeek CJ, Slotman BJ, Paul MA, Smit EF, et al. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2012;83:348–53.

5. Senan S, Brade A, Wang LH, Vansteenkiste J, Dakhil S, Biesma B, et al. PROCLAIM: Randomized Phase III Trial of pemetrexed-cisplatin or etoposide-cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced nonsquamous non-small-cell lung cancer. J Clin Oncol. 2016;34:953–62.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Salvage lung resection after immunotherapy is feasible and safe;JTCVS Open;2024-08

2. Survival impact of pathologic features after salvage lung resection following definitive chemoradiotherapy or systemic therapy for initially unresectable lung cancer;2023-10-17

3. Prognostic factors affecting survival in patients with non-small cell lung cancer treated with salvage surgery after drug therapy: a multi-institutional retrospective study;World Journal of Surgical Oncology;2023-09-15

4. Salvage Surgery for Small-Cell Lung Cancer—A Literature Review;Cancers;2023-04-11

5. Salvage surgery in lung cancer following definitive therapies;Journal of Surgical Oncology;2023-01-11